TrialBlood neoplasia2026

Tisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomas.

Julio C Chavez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.